P2.14. First-Line Envafolimab plus Carboplatin-etoposide in Extensive-Stage Small-Cell Lung Cancer: a Single-Arm Phase II Study - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Shengjie Sun
Meta Tag
Speaker Shengjie Sun
Topic SCLC & Neuroendocrine Tumors: First Line Therapy
Keywords
Phase II study
efficacy
safety
first-line treatment
envafolimab
carboplatin
etoposide
extensive-stage small-cell lung cancer
progression-free survival
combination therapy
Powered By